Velocity Clin Research Springdale — Cincinnati, Ohio

Velocity Clin Research Springdale is a clinical research site located in Cincinnati, Ohio, United States 45246.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Velocity Clin Research Springdale has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease, Cardiovascular Disease and Lipoprotein(a), Atherosclerotic Cardiovascular Disease.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cincinnati

Browse all research sites in Ohio · View every site in Cincinnati

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clin Research Springdale?

Velocity Clin Research Springdale has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clin Research Springdale conducted?

Velocity Clin Research Springdale has 3 clinical trials on record, with 2 currently active. Their work covers Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease, Cardiovascular Disease and Lipoprotein(a), Atherosclerotic Cardiovascular Disease.

Is Velocity Clin Research Springdale accredited by Crixeo Clinical Trials?

Velocity Clin Research Springdale has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clin Research Springdale?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.